NN UNG OMEGA 3 VO BUI SNG KHNG

Reimbursement Is Getting Better Insurance coverage for GLP-1 weight-loss medications is expanding rapidly : Many commercial insurers now cover Wegovy, Saxenda, and Mounjaro with prior authorization (typically requiring BMI 30 or 27 with comorbidity) Medicare will begin covering anti-obesity medications in 2026 a game-changer for providers seeing older patients State Medicaid programs are adding coverage (varies by state, but momentum is strong) For the clinical visit itself : Bill standard E/M codes (99213-99215 for follow-ups, 99202-99205 for new patients) Psychiatrists get 100% of Medicare physician fee schedule (~$75-150 per visit depending on complexity) PMHNPs typically get 85% of physician rates for Medicare (though some state Medicaid programs like Illinois pay NPs at 100%) Telehealth parity laws in CA, NY, IL, and many other states ensure equal reimbursement for video visits Typical visit economics : 15-20 minute medication management follow-up: $100-150 reimbursement Initial evaluation (45 min): $200-250 If you see 4 weight management patients per day (1 hour total), thats $400-600 in revenue Compare that to traditional psychiatric med management (already your bread and butter) its the same billing model, just applied to a different clinical problem

Semaglutide was associated with reduced alcohol consumption and blood alcohol levels during the laboratory drinking task Participants receiving semaglutide drank less (bar graph below) and achieved lower blood alcohol levels during the end of treatment alcohol self-administration paradigm
MPGF ELISA AL-175 Shah A, Dodson WC, Kris-Etherton PM, Kunselman AR, Stetter CM, Gnatuk CL, Estes SJ, Allison KC, Sarwer DB, Sluss PM, Coutifaris C, Dokras A, Legro RS
Liraglutide belongs to a class of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists
Weight regain risk varies, but sustainable routines and behaviour change usually play an important role in long-term maintenance